Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanChen‐Hua Liu, Jia‐Horng Kao, Gin‐Ho Lo et al.|Hepatology International|2021Cited by 32
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus InfectionYu‐Ping Chang, Ji‐Yuh Lee, Chi‐Yi Chen et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 12